| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.19 | 0.002 |